Valeo Pharma closes upsized $6.6M private placement

Valeo Pharma announced today that it closed an upsized private placement worth more than $6.6 million.

Montreal, Canada-based Valeo issued 6,645 unsecured, non-convertible debenture units at a purchase price of $1,000 per unit, totaling gross proceeds of 6.645 million, according to a news release.

Get the full story at our sister site, Drug Delivery Business News.

Read more
  • 0